Lingotto Investment Management LLP Invests $2.54 Million in Oscar Health, Inc. (NYSE:OSCR)

Lingotto Investment Management LLP acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 189,200 shares of the company's stock, valued at approximately $2,543,000. Lingotto Investment Management LLP owned 0.08% of Oscar Health at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in OSCR. Wealth Enhancement Advisory Services LLC raised its stake in shares of Oscar Health by 7.5% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company's stock valued at $255,000 after purchasing an additional 844 shares during the period. KBC Group NV raised its stake in shares of Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company's stock valued at $97,000 after purchasing an additional 1,328 shares during the period. Allspring Global Investments Holdings LLC raised its stake in shares of Oscar Health by 1.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 109,074 shares of the company's stock valued at $2,313,000 after purchasing an additional 1,866 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Oscar Health by 9.2% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company's stock valued at $561,000 after purchasing an additional 2,236 shares during the period. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its stake in shares of Oscar Health by 28.2% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 21,968 shares of the company's stock valued at $295,000 after purchasing an additional 4,838 shares during the period. Institutional investors and hedge funds own 75.70% of the company's stock.

Remove Ads

Insider Buying and Selling

In other news, EVP Ranmali Bopitiya sold 19,157 shares of the business's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $346,358.56. Following the completion of the sale, the executive vice president now owns 241,488 shares in the company, valued at $4,366,103.04. The trade was a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Mario Schlosser sold 6,516 shares of the business's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $117,809.28. Following the sale, the insider now owns 81,962 shares of the company's stock, valued at approximately $1,481,872.96. This represents a 7.36 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 78,610 shares of company stock worth $1,421,269. Company insiders own 25.11% of the company's stock.

Wall Street Analyst Weigh In

OSCR has been the topic of several recent research reports. Bank of America downgraded Oscar Health from a "neutral" rating to an "underperform" rating and dropped their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Jefferies Financial Group began coverage on Oscar Health in a report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Oscar Health presently has a consensus rating of "Hold" and an average price target of $21.56.

Oscar Health Stock Down 1.4 %

Shares of NYSE OSCR traded down $0.21 during mid-day trading on Friday, hitting $14.59. The company had a trading volume of 4,310,587 shares, compared to its average volume of 4,571,968. The company has a market capitalization of $3.61 billion, a PE ratio of -728.89 and a beta of 1.73. The firm has a 50-day simple moving average of $14.97 and a two-hundred day simple moving average of $16.59. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a one year low of $12.43 and a one year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. On average, equities analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.